Wednesday, 18 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

4:17 PM ET 8-K
Financial Results Corpay, Inc. CPAY

Corpay Financial Results

Corpay reported third quarter 2026 financial results with revenue growth of 18% to $1.38 billion and adjusted EPS growth of 32% to $7.54. The company raised its full-year 2026 guidance to reflect strong performance in Corporate Payments and improved expectations for the fourth quarter.

Term
Q3 2026

“Our third quarter results were excellent, with revenue growth of 18% and adjusted net income per diluted share growth of 32%, both ahead of our expectations. Organic revenue growth for the quarter was 11%. We've delivered 11% organic growth for five of the last six quarters.”

Ron Clarke, chairman and chief executive officer

“Corporate Payments delivered 18% organic revenue growth driven by strong performance in both spend management and cross-border, and we delivered 57.4% EBITDA margins due to the high flow through rate on revenue. Through the end of the quarter we've repurchased 5.25 million shares for $1.85 billion, inclusive of the 1.9 million shares repurchased for $747 million in the third quarter.”

Peter Walker, chief financial officer
4:17 PM ET 8-K
Financial Results Bio-Rad Laboratories, Inc. BIO

Bio-Rad Laboratories Financial Results

Bio-Rad Laboratories reported third-quarter 2026 financial results with net sales of $656.4 million, representing a 0.7% increase on a currency-neutral basis. The company returned to growth driven by the Clinical Diagnostics segment and Droplet Digital PCR instruments, despite ongoing challenges in the academic research market. GAAP net income was significantly impacted by a change in the fair market value of the company's investment in Sartorius AG.

Term
Q3 2026

“Our third-quarter results reflect the steady progress we have been driving. We returned to currency-neutral revenue growth, led by Clinical Diagnostics and strong demand for our Droplet Digital™ PCR instruments. Excluding restructuring and impairment items, margins expanded, reflecting benefits of our transformation initiatives. The reprioritization of our R&D efforts is yielding new, differentiated products for our customers, and our progress gives us confidence in our 2026 outlook.”

Norman Schwartz, Bio-Rad’s Chief Executive Officer
4:17 PM ET 10-Q
Financial Results Fidelity National Information Services, Inc. FIS

Fidelity National Information Services Q3 2026 Results: Net Income $356M, Up 34.8% YoY

Fidelity National Information Services (FIS) reported a significant increase in net earnings for the nine months ended September 30, 2026, reaching $2.95 billion compared to a net loss of $126 million in the prior year period, primarily driven by a $2.21 billion gain from equity method investments. Revenue grew to $10.13 billion for the nine-month period, while the company maintained a quarterly dividend of $0.44 per share.

Key figure
Net income $356M · +34.8% YoY
4:17 PM ET 8-K
Financial Results Texas Pacific Land Corp TPL

Texas Pacific Land Financial Results

Texas Pacific Land Corporation reported record third-quarter 2026 results, achieving its highest-ever consolidated revenue, net income, and free cash flow. Performance was driven by record oil and gas royalty production of 42.3 thousand Boe per day and strong midstream easement revenue as Permian Basin development activity remained robust.

“Our third quarter results were the strongest in TPL’s history with new records set across our business. TPL again generated record revenue, net income, and free cash flow. Our royalty acreage benefited from robust development activity, elevated oil prices, and improved gas realizations, driving record oil and gas royalty revenue.”

Tyler Glover, Chief Executive Officer
4:17 PM ET 10-Q
Financial Results Phibro Animal Health Corp PAHC ▶ Call

Phibro Animal Health Q1 2026 Results: Net Income $29.5M, Up 11.3% YoY

Phibro Animal Health Corp reported net sales of $386.8 million for the quarter ended September 30, 2026, a 6% increase compared to the prior year. Net income rose to $29.5 million ($0.72 per diluted share) from $26.5 million, driven by higher sales volume and improved foreign currency impacts despite an increase in selling, general, and administrative expenses.

Key figure
Net income $29.5M · +11.3% YoY
4:17 PM ET 8-K
Financial Results Dutch Bros Inc. BROS

Dutch Bros Financial Results

Dutch Bros Inc. reported third quarter 2026 financial results with 29.8% revenue growth and positive same-shop sales growth of 4.4% systemwide. The company raised its full-year 2026 revenue guidance to at least $2.1 billion and announced an accelerated goal of opening approximately 250 new shops in 2027.

Term
Q3 2026

“Dutch Bros continues to gain share in the high-growth beverage category. In the third quarter, we achieved our fourteenth consecutive quarter of positive same shop sales and ninth consecutive quarter of same shop customer visit growth. This is a testament to the strength of our brand, our differentiated people-led culture, and our strategic focus on expanding customer occasions.”

Christine Barone, Chief Executive Officer and President

“The investments we’ve made in our people, tools, and processes over the past several years have enabled seamless execution by our teams and strengthened the foundation of our business. As we look ahead to 2027, we’re building on that foundation and unlocking new growth opportunities across the business. From accelerating our pace of beverage innovation to testing new hot food platforms, enhancing digital capabilities and piloting delivery, we’re creating more reasons for new and existing customers to choose Dutch Bros.”

Christine Barone, Chief Executive Officer and President
4:17 PM ET 8-K
Leadership Change Morgan Stanley Solana Trust MSOL

Morgan Stanley Solana Trust Leadership Change

Sally Diffley resigned as Chief Financial Officer of Morgan Stanley Investment Management Inc., the delegated sponsor of the Morgan Stanley Solana Trust. Swapnil Parab, currently the Head of Financial Planning and Analysis for Morgan Stanley Investment Management, has been appointed as the new CFO effective November 4, 2026.

4:17 PM ET Form 4
Insider Selling Spok Holdings, Inc SPOK

Spok Holdings Director Brett A. Shockley Sells $196K of Stock

Brett A. Shockley, Director, sold 16,245 shares of Spok Holdings, Inc at $12.04 to $12.12 a share (average $12.05) in 2 transactions, worth $196K in total on Nov 2, 2026. Shares held after the trade: 26,817 (-5.2%).

Value
$196K
Shares
16,245
Average price
$12.05
Role
Director
Holding change
-5.2%
Trade date
Nov 2, 2026
4:17 PM ET Form 4
Insider Selling Oklo Inc. OKLO

Oklo Co-Founder, COO Caroline Cochran Sells $1.97M of Stock

Caroline Cochran, Co-Founder, COO, sold 80,000 shares of Oklo Inc. at $23.82 to $25.69 a share (average $24.64) in 6 transactions, worth $1.97M in total on Nov 2, 2026. Shares held after the trade: 351,533 (-1.9%).

Value
$1.97M
Shares
80,000
Average price
$24.64
Role
Co-Founder, COO
Holding change
-1.9%
Trade date
Nov 2, 2026
4:17 PM ET 8-K
Financial Results Outset Medical, Inc. OM

Outset Medical Financial Results

Outset Medical reported third quarter 2026 revenue of $33.6 million, a 14% increase year-over-year, driven by strong growth in console and recurring revenue. The company reduced its net loss to $14.7 million from $17.8 million in the prior-year period while expanding gross margins to 40.7%. Management reiterated its full-year 2026 revenue guidance of $125 million to $130 million.

Term
Q3 2026

“Third-quarter results demonstrated continued progress against our strategic priorities and solid sales execution across both capital and recurring revenue. Consistently strong customer satisfaction and retention are expanding adoption of Tablo across our existing customer base and fueling new insourced dialysis partnerships with leading health systems. Advancing our mission to help providers nationwide improve the cost, complexity and clinical outcomes of dialysis continues to position Outset well for sustained long-term growth and value creation.”

Leslie Trigg, Chair and Chief Executive Officer
4:17 PM ET 10-Q
Financial Results electroCore, Inc. ECOR

electroCore Q3 2026 Results: Net Loss of $1.34M, Loss Narrows

electroCore, Inc. reported net sales of $9.69 million for the third quarter of 2026, an increase from $8.69 million in the prior year period. The company's net loss narrowed to $1.34 million for the quarter compared to $3.41 million in 2025, driven by higher gross profits and a reduction in total operating expenses.

Key figure
Net loss $1.34M
4:17 PM ET 8-K
Financial Results Cytek Biosciences, Inc. CTKB

Cytek Biosciences Financial Results

Cytek Biosciences reported Q3 2026 revenue of $53.2 million, a 2% increase year-over-year, driven by 12% growth in the U.S. market and strong demand for high-end instruments. The company achieved a GAAP gross margin of 59% and narrowed its full-year 2026 revenue guidance to a range of $208 million to $211 million.

Term
Q3 2026

“We delivered another solid third quarter, with growth led by the U.S., where revenue grew 12%, and double-digit growth in our service business. Demand for our high-end instruments remained strong, with high-end Full Spectrum Profiling instrument revenue up 11% and Aurora Evo placements nearly doubling year over year. We also expanded gross margin by nearly 600 basis points. Looking ahead, we are reiterating the midpoint of our full-year revenue guidance and expect a strong finish to the year. We are well positioned to keep gaining market share, with our new product launches continuing to strengthen our technology leadership.”

Wenbin Jiang, CEO of Cytek Biosciences
4:17 PM ET 8-K
M&A Deal Non Invasive Monitoring Systems Inc NIMU

Non Invasive Monitoring Systems M&A Deal with Gravitics, Inc.

Non-Invasive Monitoring Systems, Inc. entered into a fifth amendment to its merger agreement with Gravitics, Inc., extending the outside closing and termination date from October 30, 2026, to November 30, 2026. Additionally, the company extended the maturity dates for several affiliate promissory notes and a $0.81 million convertible note to align with the new merger timeline.

Counterparty
Gravitics, Inc.
4:17 PM ET 10-Q
Financial Results Millrose Properties, Inc. MRP

Millrose Properties Q3 2026 Results: Net Income $130M, Up 23.7% YoY

Millrose Properties, Inc. is a real estate investment trust (REIT) that operates a homesite option platform, primarily serving Lennar and Rausch Coleman Companies following its spin-off from Lennar in February 2025. As of November 3, 2026, the company had 154,228,116 Class A and 11,819,811 Class B common shares outstanding. The filing highlights its transition to an independent entity and its reliance on master agreements with homebuilders for revenue and land asset management.

Key figure
Net income $130M · +23.7% YoY
4:17 PM ET 8-K
Financial Results Coca-Cola Consolidated, Inc. COKE

Coca-Cola Consolidated Financial Results

Coca-Cola Consolidated reported third quarter 2026 net sales of $1.99 billion, a 5.4% increase driven by pricing actions and volume growth. Income from operations rose 10.1% to $271.6 million, while the company highlighted a $450 million debt reduction year-to-date through October.

Term
Q3 2026

“Our third quarter results reflect the strength of our business and the dedication of our teammates to serving our customers and consumers every day. Our net sales growth reflects a healthy balance of volume and price which, combined with our focus on local execution, continues to position us for long-term growth.”

J. Frank Harrison, III, Chairman and Chief Executive Officer
4:17 PM ET 10-Q
Financial Results Zevia PBC ZVIA ▶ Call

Zevia PBC Q3 2026 Results: Net Loss of $2.11M, Loss Narrows

Zevia PBC reported a net loss for the third quarter of 2026, with the denominator for loss per share including vested but unreleased RSUs. The company maintained its revolving credit facility and entered into a new corporate headquarters lease in April 2026. Revenue remains concentrated among a few key customers, with Customer A and Customer C representing significant portions of total sales.

Key figure
Net loss $2.11M
4:17 PM ET 10-Q
Financial Results Performance Food Group Co PFGC

Performance Food Group Q1 2026 Results: Net Income $130M, Up 38.4% YoY

Performance Food Group reported net sales of $18.0 billion for the quarter ended September 26, 2026, a 5.5% increase over the prior year. Net income rose significantly to $129.5 million compared to $93.6 million in the previous year, driven by higher gross profit and improved operating margins.

Key figure
Net income $130M · +38.4% YoY
4:17 PM ET 10-Q
Financial Results Relay Therapeutics, Inc. RLAY

Relay Therapeutics Q3 2026 Results: Net Loss of $81.7M, Loss Widens

Relay Therapeutics is a large accelerated filer with 220,959,470 shares of common stock outstanding as of October 30, 2026. The company remains a clinical-stage biopharmaceutical firm with no product revenue, incurring significant operating losses while focusing on the development of its precision medicine pipeline.

Key figure
Net loss $81.7M
4:17 PM ET 8-K
Leadership Change Morgan Stanley Ethereum Trust MSSE

Morgan Stanley Ethereum Trust Leadership Change

Sally Diffley resigned as Chief Financial Officer of Morgan Stanley Investment Management Inc., the delegated sponsor of the Morgan Stanley Ethereum Trust. Swapnil Parab, currently the Head of Financial Planning and Analysis for Morgan Stanley Investment Management, was appointed to succeed her as CFO effective November 4, 2026.

4:17 PM ET 8-K
Leadership Change Morgan Stanley Bitcoin Trust MSBT

Morgan Stanley Bitcoin Trust Leadership Change

Sally Diffley resigned as Chief Financial Officer of Morgan Stanley Investment Management Inc., the delegated sponsor of the Morgan Stanley Bitcoin Trust. Swapnil Parab, currently the Head of Financial Planning and Analysis for Morgan Stanley Investment Management, was appointed as her successor effective November 4, 2026.

4:17 PM ET 8-K
Investor Presentation Global Net Lease, Inc. GNL

Global Net Lease Investor Presentation

Global Net Lease, Inc. has prepared a formal investor presentation for the third quarter of 2026 to be used at upcoming conferences and meetings with investors. The presentation deck, filed as Exhibit 99.1, provides a strategic and operational overview of the company's real estate portfolio and growth strategies.

4:16 PM ET 8-K
Financial Results Adaptive Biotechnologies Corp ADPT

Adaptive Biotechnologies Financial Results

Adaptive Biotechnologies reported Q3 2026 financial results, achieving total company profitability ahead of expectations with $83.9 million in revenue and $2.8 million in net income. The company saw 44% growth in core MRD revenue (excluding milestones) and increased its full-year 2026 MRD revenue guidance. Management highlighted momentum in clonoSEQ testing and updated clinical guidelines for multiple myeloma as key growth drivers.

Term
Q3 2026

“Adaptive achieved total company profitability ahead of expectations in Q3 and delivered 44% growth in core MRD revenue. This momentum supports another increase in our full year outlook. Updated guidelines and a new definition of cure for multiple myeloma amplify the need for MRD testing and bolster clonoSEQ’s long-term potential.”

Chad Robins, chief executive officer and co-founder of Adaptive Biotechnologies
4:16 PM ET 8-K
Financial Results Fair Isaac Corp FICO

Fair Isaac Financial Results

Fair Isaac Corp (FICO) reported Q4 fiscal 2026 revenue of $657 million, a 27% increase year-over-year, driven by a 33% jump in Scores revenue. GAAP net income was $175 million, which included a $65 million antitrust settlement accrual and a $48 million gain from an equity investment sale. Software Annual Recurring Revenue (ARR) grew 14% year-over-year, led by a 72% increase in platform ARR.

Term
Q4 2026

“I am proud of our performance in FY26. Our team continues to execute well despite a turbulent macro environment.”

Will Lansing, chief executive officer
4:16 PM ET 8-K
Financial Results Palomar Holdings, Inc. PLMR

Palomar Holdings Financial Results

Palomar Holdings reported record third quarter 2026 results, with gross written premiums increasing 28.4% to $767.0 million and adjusted net income rising 47.4% to $81.3 million. The company achieved an adjusted return on equity of 33.1% and raised its full-year 2026 adjusted net income guidance for the fourth time this year.

Term
Q3 2026

“Palomar’s third quarter of 2026 was exceptional; highlighted by record gross written premium and adjusted net income, our 16th consecutive earnings beat and the fourth increase to our 2026 adjusted net income guidance range. Profitable growth anchors Palomar 2X. This quarter’s 47% growth in adjusted net income and 33% adjusted return on equity demonstrate our ability to deliver on that strategy in a dynamic insurance market.”

Mac Armstrong, Chairman and Chief Executive Officer

“We were especially pleased with written premium growth across all five product categories this quarter: Earthquake, Inland Marine and Property, Casualty, Crop and Surety & Credit. Our “one-of-one” specialty product portfolio is well positioned across market cycles, and this quarter reflected the ballast, diversity and overall strength in the book. It continues to position Palomar for long-term success and shareholder value creation.”

Mac Armstrong, Chairman and Chief Executive Officer
4:16 PM ET 10-Q
Financial Results Allient Inc ALNT

Allient Q3 2026 Results: Net Income $15.3M, Up 136.6% YoY

Allient Inc. reported significant growth for the third quarter of 2026, with revenues increasing to $164.4 million from $138.7 million in the prior year period. Net income more than doubled to $15.3 million, or $0.91 per diluted share, driven by higher gross profits and reduced interest expenses.

Key figure
Net income $15.3M · +136.6% YoY
4:16 PM ET 8-K
Financial Results Palmer Square Capital BDC Inc. PSBD

Palmer Square Capital BDC Financial Results

Palmer Square Capital BDC Inc. reported third quarter 2026 financial results with net investment income of $11.6 million ($0.38 per share) and a net asset value of $13.34 per share. The company declared a fourth quarter base dividend of $0.36 per share and highlighted its share repurchase of $5.2 million during the period.

“Palmer Square Capital BDC delivered strong financial performance in the third quarter, supported by our active portfolio management and capital allocation strategy. During the quarter, we repurchased approximately $5.2 million of shares, demonstrating our commitment to enhancing shareholder value against a fluid market backdrop.”

Christopher D. Long, Chairman and Chief Executive Officer
4:16 PM ET 10-Q
Financial Results Champion Homes, Inc. SKY

Champion Homes Q2 2026 Results: Net Income $52.7M, Down 9.5% YoY

Champion Homes reported net sales of $727.0 million for the quarter ended September 26, 2026, a 6.2% increase over the prior year, though net income attributable to the company decreased to $52.7 million from $58.2 million. The company maintained a strong liquidity position with $702.8 million in cash and cash equivalents while continuing its capital return strategy through $100.0 million in common stock repurchases during the first six months of the fiscal year.

Key figure
Net income $52.7M · -9.5% YoY
4:16 PM ET 10-Q
Financial Results Prudential Financial Inc PRU ▶ Call

Prudential Financial Q3 2026 Results: Net Income $1.39B, Down 3.0% YoY

Prudential Financial reported total assets of $771.4 billion as of September 30, 2026, a slight decrease from $773.7 billion at year-end 2025. The company maintains a significant investment portfolio of $470.8 billion and reported 343 million common shares outstanding as of October 30, 2026.

Key figure
Net income $1.39B · -3.0% YoY
4:16 PM ET 8-K
Financial Results Ardent Health, Inc. ARDT

Ardent Health Financial Results

Ardent Health reported third quarter 2026 total revenue of $1.62 billion, a 3.1% increase year-over-year, and net income of $45 million. The company raised its full-year 2026 Adjusted EBITDA guidance midpoint by 1.5% based on year-to-date performance and operational momentum from its IMPACT initiatives.

“We delivered strong third quarter results, highlighted by adjusted EBITDA of $138 million, a 4% reduction in SWB expense, and 2.9% adjusted admissions growth. Our performance reflects disciplined execution, with volumes improving sequentially and continued progress on our operating priorities. IMPACT initiatives continued to gain traction and remain on track to achieve at least $70 million of savings this year, contributing to greater efficiency and stronger financial performance.”

Dave Caspers, President and Chief Executive Officer of Ardent Health

“We enter the fourth quarter with confidence in the trajectory of our business and ability to execute on the opportunities ahead. Based on our year-to-date performance and continued operational momentum, we are raising our 2026 Adjusted EBITDA guidance midpoint 1.5%.”

Dave Caspers, President and Chief Executive Officer of Ardent Health
4:16 PM ET 8-K
Financial Results Cadre Holdings, Inc. CDRE

Cadre Holdings Financial Results

Cadre Holdings reported Q3 2026 net sales of $202.9 million, a 30% increase year-over-year, and net income of $16.0 million. The company raised its full-year 2026 guidance for the second consecutive quarter and announced an inaugural $100 million stock repurchase program.

Term
Q3 2026

“Our third-quarter results reflect strong execution across Cadre’s businesses, with double-digit organic growth and contributions from acquisitions driving a 30% increase in sales. Net income increased 46% and Adjusted EBITDA margin expanded 110 basis points to 20.2%.”

Warren Kanders, CEO and Chairman

“Heightened geopolitical uncertainty, evolving public-safety requirements and investment in nuclear infrastructure create enduring demand drivers for our mission-critical products. Against this backdrop, healthy customer demand and another quarter of better-than-expected results support our decision to again raise full-year guidance.”

Warren Kanders, CEO and Chairman

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.